Exhibit 99.1



Ridgefield Acquisition Corp. Announces Results of Special Meeting of
Shareholders
Wednesday June 21, 8:30 am ET

DANBURY, Conn.--(BUSINESS WIRE)--June 21, 2006--Ridgefield Acquisition Corp.
(OTCBB: RDGA - News) - announced the results of its Special Meeting of
Shareholders ("Special Meeting"), which was held on June 16, 2006. Only
shareholders of record as of April 28, 2006 were entitled to vote at the Special
Meeting.

The shareholders approved and adopted a Plan of Merger to merge the Company with
and into Ridgefield Acquisition Corp., a newly formed Nevada corporation which
is a wholly owned subsidiary of the Company, in order to effectuate the
reincorporation of the Company as a Nevada corporation, and, among other things,
increase the Company's authorized capital and change the Company's articles of
incorporation and bylaws.


"The Company believes that the passing of the proposal by the shareholders of
the Company will improve its ability to consummate a merger, acquisition or
other business combination transaction that will increase shareholder value,"
stated Mr. Bronson.


Additionally, the shareholders re-elected all three of the sitting directors of
the Company at the Special Meeting. Specifically, the shareholders elected
Steven N. Bronson, Kenneth Schwartz and Leonard Hagan to serve on the Board of
Directors of the Company until their successors shall have been duly elected and
qualified.


Finally, the shareholders ratified and approved the Board of Directors'
appointment of Carlin, Charron & Rosen LLP as the Company's independent auditors
for fiscal year 2006.


As previously disclosed, in April 2006, the Board of Directors of the Company
authorized the spin-off of 100% of the Company's wholly owned subsidiary
Bio-Medical Automation, Inc. to the Company's shareholders as of April 28, 2006
on a pro rata basis (the "Spin-Off"). Each shareholder of the Company will
receive one (1) share of Bio-Medical Automation, Inc. for each one (1) share of
the Company owned by such shareholder as of April 28, 2006. The shares of
Bio-Medical Automation, Inc. will be issued to the shareholders of the Company
upon the effectiveness of the registration statement on Form 10-SB under the
Exchange Act. The Company anticipates that the Spin-Off will be completed in the
second half of 2006.


About Ridgefield Acquisition Corp.


Ridgefield Acquisition Corp., a Colorado corporation, whose securities are
traded on the NASDAQ Over-the-Counter Bulletin Board, is primarily engaged in
seeking to arrange for a merger, acquisition, business combination or other
arrangement by and between the Company and a viable operating entity.


About Bio-Medical Automation, Inc.


Bio-Medical Automation, Inc. is a Nevada corporation and wholly owned subsidiary
of Ridgefield Acquisition Corp. Since May 13, 2003, Bio-Medical Automation, Inc.
has been the holder of a patent for an automated system and method for
microdissection of samples such as chromosomes or other biological material, and
in particular, relates to a robotic assisted microdissection system and method
that significantly reduces the time and skill needed for cellular and
sub-cellular dissections. The system and method covered by the patent attempts
to provide reliability and ease of operation thereby making microdissection
widely available to laboratories. While Bio-Medical Automation, Inc. has never
derived any revenues from the micro-robotic device, Bio-Medical Automation, Inc.
plans to attempt to exploit, license and/or sell the technology covered by the
patent. There can be no assurances that Bio-Medical Automation, Inc. will be
able to successfully market the technology covered by the patent or that
Bio-Medical Automation, Inc. will ever derive any revenues from the patent or
the technology covered by the patent.







Statement as to Forward-Looking Statements


The Private Securities Litigation Reform Act of 1995 provides a "safe harbor"
for forward-looking statements. Certain information included in this press
release (as well as information included in oral statements or other written
statements made or to be made by the Company) contain statements that are
forward looking, such as statements relating to the future anticipated direction
of the industry, plans for future expansion, various business development
activities, planned capital expenditures, future funding sources, anticipated
transactions and potential contracts. Such forward-looking information involves
important risks and uncertainties that could significantly affect anticipated
results in the future and, accordingly, such results may differ form those
expressed in any forward-looking statements made by or on behalf of the Company.
These risks and uncertainties include, but are not limited to, those relating to
development and expansion activities, dependency on existing management,
financing activities, domestic and global economic conditions, changes in
federal or state tax laws and market competition factors. We undertake no
obligation to update information in this release.


Contact:
Ridgefield Acquisition Corp.
Steven N. Bronson, President, 203-791-3871